USP Releases Proposed Standard on Supply Chain Integrity and Counterfeits
Posted 05 January 2012 | By
The US Pharmacopeia (USP) released new proposed standards last week that are aimed at securing global supply chains and preventing counterfeit medicines from propagating.
The standards-composed of a series of best practices-would ensure that:
- products are traceable to their original manufacturers;
- product integrity is ensured in both substance and identity; and
- product quality is maintained from manufacturer to consumer
Further, the best practices would ensure these goals by addressing four principle areas:
- the importation of products, including the management of supply chain risk, and development of supplier partnerships and supply chain quality systems;
- counterfeit products and the scope of the problem;
- best practices to confront the counterfeiting of drugs and devices through packaging, pedigrees, intelligent tagging, security, and other international best practices; and
- risk reduction, prevention, and response
Comments on the proposal, General Chapter 1083, Good Distribution practices-Supply Chain integrity, are due on 31 May, 2012.